Fact-checked by Grok 2 weeks ago

Axon terminal

The axon terminal, also known as the synaptic bouton or terminal bouton, is the distal end of a neuron's where synaptic vesicles containing neurotransmitters are stored and released to transmit signals to adjacent neurons, muscle cells, or cells. These specialized structures form the presynaptic component of chemical synapses, facilitating communication across the synaptic cleft—a narrow gap of 20–40 nm—through the of neurotransmitters triggered by calcium influx upon arrival of an . Structurally, axon terminals are bulbous swellings or varicosities at the end of axonal branches, lacking ribosomes and rough but rich in mitochondria, , neurofilaments, and synaptic vesicles clustered near the active zone for rapid release. Functionally, they convert electrical impulses into chemical signals, enabling excitatory or inhibitory essential for integration, learning, , and , with systems delivering vesicles and proteins at rates up to 400 mm/day. In , axon terminals appear as tapered telodendrons under light microscopy with stains like Golgi, and electron microscopy reveals their synaptic knobs in direct to postsynaptic densities. Disruptions in axon terminal function, such as impaired neurotransmitter release, underlie various neurodegenerative diseases.

Anatomy and Structure

Location and Types

The axon terminal, also known as the synaptic bouton or end-foot, represents the distal extremity of a neuron's , where it interfaces with target cells to convert electrical impulses into chemical signals via release at synapses. This specialized structure is primarily situated at the far end of the , often branching into fine extensions termed telodendria that facilitate multiple synaptic connections. In some cases, axon terminals form along the axon's length rather than solely at its terminus, allowing for interspersed synaptic contacts without dedicated end structures. Axon terminals exhibit morphological diversity depending on their neural context, categorized into several types based on size, shape, and target tissue. Terminal boutons are enlarged, bulbous swellings typically found at the 's , serving as presynaptic sites for synaptic . Varicosities, or bead-like enlargements, occur along unmyelinated s and are common in autonomic fibers, forming diffuse release sites rather than discrete synapses. Neuromuscular junctions constitute a distinct type in the peripheral , featuring expanded terminals that form specialized end plates on fibers for robust motor signaling. In the (CNS), axon terminals often manifest as multiple small boutons, either as terminal ends or en passant swellings, enabling widespread connectivity among neurons, as observed in hippocampal circuits. Conversely, in the peripheral nervous system (PNS), terminals tend to be larger and more specialized; for instance, motor neurons form expansive neuromuscular end plates on , while autonomic terminals in display varicosities for broader effector influence. These variations reflect adaptations to the functional demands of neural circuits, with CNS terminals prioritizing precision and PNS terminals emphasizing force or modulation.

Ultrastructure and Components

The axon terminal, or presynaptic bouton, exhibits a highly organized adapted for efficient synaptic function, featuring a dense array of organelles and protein complexes within a typically measuring 0.4–1 μm in diameter. Electron microscopy reveals a cytoplasmic matrix filled with synaptic vesicles clustered near the presynaptic membrane, interspersed with mitochondria and segments of (), all anchored by a filamentous cytomatrix that provides structural support and . This architecture ensures precise positioning of components at the active zone, the specialized site of release. Synaptic vesicles represent the primary vesicular components, existing in two main forms: clear synaptic vesicles, approximately 40–50 nm in diameter, which store small-molecule neurotransmitters, and dense-core vesicles, larger at 80–120 nm, containing neuropeptides or larger signaling molecules. These vesicles, numbering 100–500 per terminal, are clustered and tethered via filamentous connectors less than 40 nm long, forming organized pools within the cytomatrix. Mitochondria, often small and elongated with volumes ranging from 0.04 to 0.38 μm³ depending on the region, are embedded throughout the terminal, maintaining a compact confined within presynaptic boundaries. The ER manifests as a network of anastomosed tubules or small cisternae with narrow lumens, branching within the terminal to envelop mitochondria and vesicles, forming close structural contacts that integrate positioning. The active zone forms a protein-dense disc-like region, 0.2–0.5 μm wide and 50–100 nm thick, embedded in the presynaptic membrane and serving as the primary docking platform for vesicles. This zone comprises a cytomatrix of interconnected filaments and tethers, including short projections (5–20 nm) that link vesicles to the membrane, organized in a hexagonal grid-like array. Key scaffold proteins such as and Munc13 concentrate here, forming a core complex that mediates vesicle docking sites and stabilizes the presynaptic density. The presynaptic cytomatrix extends beyond the active zone as a filamentous meshwork, interconnecting over 80% of vesicles into clusters and anchoring organelles to prevent diffusion. Ultrastructural variations occur across synapse types, notably in ribbon synapses of sensory neurons, where a prominent electron-dense ribbon structure tethers hundreds of vesicles in a stacked, perpendicular array to the active zone, facilitating sustained release. In contrast, conventional terminals display more compact vesicle pools without such ribbons, emphasizing the adaptability of the axon terminal's internal architecture to specialized signaling demands.

Function in Neural Communication

Role in Synaptic Transmission

The terminal functions primarily as the presynaptic site in chemical synapses, where it receives action potentials propagating along the and initiates the release of neurotransmitters across the synaptic cleft to convey signals to adjacent neurons or target cells. This process transforms electrical impulses into chemical messengers, enabling targeted intercellular communication essential for neural signaling. As the endpoint of the , the terminal ensures that signals terminate appropriately, preventing indiscriminate propagation and allowing for localized influence on postsynaptic elements. Within neural circuits, axon terminals serve as the presynaptic components that enforce unidirectional transmission in most chemical synapses, directing information flow from one neuron to another or to effectors like muscle cells. They integrate into diverse synaptic configurations, such as axodendritic connections on dendrites for excitatory input or axosomatic synapses on cell bodies for inhibitory modulation, thereby contributing to the of neural networks. This presynaptic positioning allows terminals to regulate the timing and strength of signals, facilitating coordinated activity across brain regions and spinal circuits. Axon terminals participate in both excitatory and inhibitory signaling pathways; for instance, terminals in the release glutamate to depolarize postsynaptic neurons, promoting excitation, while GABAergic terminals release to hyperpolarize targets, suppressing activity. In the peripheral nervous system, terminals at neuromuscular junctions release onto fibers, generating endplate potentials that initiate contraction and support motor function. These roles highlight the terminal's versatility in modulating neural output and effector responses. The terminal's involvement in synaptic exhibits evolutionary conservation, with similar presynaptic structures and release functions present in nervous systems from , such as nematodes and , to vertebrates including mammals. This preservation across metazoans underscores the terminal's ancient origin and critical role in the development of complex neural communication.

Signal Arrival and Processing

The arrival of an electrical signal at the axon terminal occurs through the propagation of an along the , which is initiated at the axon and travels toward the terminal via sequential activation of voltage-gated sodium channels. These channels open in response to local , allowing a rapid influx of Na⁺ ions that further depolarizes the and propagates the signal in a self-regenerating manner. Upon reaching the axon terminal, the causes a localized of the presynaptic , setting the stage for chemical . In the axon terminal, which often features branched structures, the invading can actively propagate into these fine branches, though propagation may fail in narrower or more distal segments due to increased axial resistance and reduced safety factors for conduction. This local processing includes potential from the terminal toward the in some cases, but failures at branch points can lead to variable signal fidelity across terminals of the same . Such dynamics ensure that not all branches necessarily receive the full amplitude of the action potential, influencing the reliability of synaptic output. Myelination along the plays a crucial role in efficient signal delivery to the unmyelinated terminal regions by enabling , where the action potential jumps between —gaps in the sheath enriched with voltage-gated sodium channels. The final , typically located just proximal to the , regenerates the action potential with high fidelity, preventing decrement as the signal transitions into the unmyelinated terminal zone. This mechanism minimizes conduction delays and energy expenditure, ensuring timely at the . At the axon terminal, the depolarizing signal interacts with discrete release sites on the presynaptic , where release follows quantal principles: each site has an associated probability (p) of releasing a quantum of transmitter in response to the action potential, with the number of sites (n) determining the potential scale of release. This probabilistic framework, established through quantal analysis, underscores the nature of at the terminal without implying deterministic fusion events. Representative studies at the have quantified these parameters, showing mean quantal content () values around 100-200 under physiological conditions, highlighting the terminal's capacity for reliable yet variable transmission.

Neurotransmitter Release Mechanisms

Vesicular Exocytosis Process

The vesicular process at the axon terminal involves a series of tightly regulated stages that enable synaptic vesicles to release into the synaptic cleft. Synaptic vesicles, filled with neurotransmitters, initially undergo at the presynaptic plasma membrane near the active . This is mediated by the formation of trans-SNARE complexes, where v-SNARE (, or synaptobrevin) on the vesicle membrane interacts with t-SNAREs (syntaxin and SNAP-25) on the plasma membrane, bridging the two bilayers and positioning the vesicle for subsequent steps. Following , the vesicles enter a , where the SNARE proteins into a four-helix bundle, stabilizing the complex and preparing the vesicle for by dehydrating the intervening space between membranes. then occurs as the SNARE complex drives the merging of vesicle and plasma membranes, releasing the vesicle contents into the cleft through a transient fusion pore. Exocytosis can proceed via two primary modes: synchronous and asynchronous. Synchronous exocytosis is rapid and tightly coupled to action potential arrival, involving coordinated of multiple vesicles to ensure precise temporal signaling in neural communication. In contrast, asynchronous exocytosis features delayed and more variable release events, often manifesting as spontaneous miniature synaptic currents independent of immediate stimulation, which contributes to baseline synaptic tone and . Both modes rely on the core SNARE-mediated machinery but differ in their and within the terminal. After fusion, synaptic vesicles are recycled to sustain repeated release, primarily through two exocytosis subtypes: full fusion and kiss-and-run. In full fusion, the vesicle completely collapses into the plasma , dispersing its lipids and proteins, which necessitates retrieval via clathrin-mediated endocytosis to reform vesicles. Clathrin-mediated endocytosis involves the assembly of coats on the , invagination, and pinching off to generate new vesicles that are refilled with . Alternatively, kiss-and-run fusion allows partial merging via a narrow pore, enabling neurotransmitter release without full collapse, followed by rapid vesicle retrieval and reuse, which supports high-frequency transmission. The timing of is highly precise, with release occurring within a 1-2 ms window following terminal depolarization, ensuring minimal delay in synaptic transmission. This rapidity is governed by the dynamics of vesicle pools, particularly the readily releasable pool (RRP), which comprises approximately 5-10 docked and primed vesicles per active zone site, available for immediate fusion upon stimulation. The RRP size limits the initial burst of release, after which replenishes the pool to maintain synaptic .

Calcium-Dependent Regulation

Upon arrival of an at the axon terminal, activates voltage-gated calcium channels, primarily P/Q-type (CaV2.1) and N-type (CaV2.2), which are clustered at the presynaptic active zones. These channels open rapidly, permitting a brief influx of Ca²⁺ ions that directly triggers fusion and release. The influx is tightly coupled to , occurring within microseconds to ensure precise temporal control of transmission. The Ca²⁺ signal is confined to localized microdomains near the channels, where concentrations transiently rise to 10–100 μM at the active zones, far exceeding bulk cytosolic levels of ~100 nM. These nanometer-scale gradients bind to synaptotagmin-1 (or isoforms like synaptotagmin-2), the primary Ca²⁺ sensor on the vesicle surface, which undergoes a conformational change to promote SNARE-mediated membrane fusion. Synaptotagmin's C2 domains exhibit high-affinity Ca²⁺ , enabling synchronous release with . Release probability (Pr) is finely tuned by factors such as channel density at active zones and endogenous Ca²⁺ buffers, which shape the microdomain profile and coupling distance to vesicles. Higher channel density increases Pr by enhancing local Ca²⁺ elevation, while buffers like limit diffusion to sustain . Quantitatively, Pr follows a steep sigmoidal dependence on [Ca²⁺], approximated by a Hill-like function with cooperativity n = 3–5: P_r \approx 1 - e^{-\frac{[\mathrm{Ca}^{2+}]^n}{K_d}} where Kd is the half-activation constant (~10–50 μM), reflecting the nonlinear amplification of release. This steepness ensures all-or-none responses to action potentials. Negative feedback via presynaptic autoreceptors, such as GABAB or muscarinic types, inhibits Ca²⁺ channels through G-protein βγ subunits, reducing influx and Pr to prevent excessive release. Conversely, second messengers like cAMP, activated by adenylyl cyclase, enhance transmission by phosphorylating channels via PKA to increase conductance or by promoting vesicle priming and tighter channel-vesicle coupling. These modulations adjust synaptic strength dynamically without altering basal Ca²⁺ dynamics.

Imaging and Visualization

Optical and Functional Imaging

Optical and functional imaging techniques enable the visualization of dynamic processes in living axon terminals, such as calcium influx and neurotransmitter release, providing insights into synaptic activity without disrupting neural function. These methods rely on fluorescent indicators that report changes in ion concentrations or molecular events associated with vesicle fusion. , for instance, uses synthetic dyes like Fluo-4, which exhibit increased upon binding intracellular calcium, allowing real-time monitoring of action potential-evoked calcium transients in presynaptic terminals. Genetically encoded calcium indicators (GECIs), such as variants of , offer targeted expression in axons and superior signal-to-noise ratios for long-term imaging . To observe exocytosis directly, —a pH-sensitive GFP fused to the luminal domain of —serves as a key reporter, as synaptic vesicles acidify during and neutralize upon with the plasma membrane, causing a rapid increase. This probe has been widely applied to track vesicle recycling dynamics at individual presynaptic sites, revealing the spatial and temporal patterns of release events. Advanced genetically encoded sensors further refine these measurements; GCaMP6 variants, for example, provide high sensitivity to calcium dynamics in synaptic terminals, enabling detection of single action potentials with precision during high-frequency stimulation. For release, iGluSnFR sensors monitor glutamate kinetics by binding extracellular glutamate and fluorescing proportionally, capturing quantal release profiles from presynaptic terminals at frequencies up to 100 Hz. These tools facilitate applications, such as quantifying release probability at single synapses using two-photon , which achieves sub-micron to isolate terminal-specific calcium signals and correlate them with postsynaptic responses in hippocampal circuits. Recent advances incorporate super-resolution techniques like to track vesicle movements on the nanoscale, resolving fusion pore dynamics and in live axon terminals with ~50 nm precision. Post-2020 developments in have enabled terminal-specific stimulation, such as projection-targeted variants that activate presynaptic sites without somatic interference, allowing precise control of release probability and integration with for studying circuit-level . These combined approaches have illuminated activity-dependent modulation of axon terminal function in behaving animals.

Structural Imaging Techniques

Structural imaging techniques for axon terminals have evolved from early histological methods to advanced electron and light microscopy approaches, enabling detailed visualization of their static architecture. In the late 1890s, utilized the Golgi staining technique to observe and illustrate axon terminals, revealing their branching patterns and synaptic contacts in neural tissue for the first time. This method impregnated neurons with , selectively staining entire cells including terminals, which laid the foundation for understanding presynaptic structures. Electron microscopy (EM) remains the gold standard for resolving the of axon terminals at nanometer scales. (TEM) provides high-contrast images of synaptic vesicles, active zones, and mitochondrial distributions within fixed terminals by passing electrons through ultrathin sections. For three-dimensional () analysis, serial section EM involves cutting consecutive thin sections of , imaging each with TEM, and computationally reconstructing synaptic boutons to map their volume and connectivity. This approach has quantified bouton morphologies, such as en passant versus varicosity types, in regions like the . Immuno-EM enhances specificity by labeling proteins in axon terminals using gold particle conjugates. In pre-embedding or post-embedding protocols, antibodies against markers like are visualized as electron-dense particles (typically 10-20 in diameter) clustered amid synaptic vesicles in presynaptic terminals. For instance, large particles (15-20 ) have been used to tag in hippocampal cultures, confirming its localization to vesicle pools. This technique distinguishes terminal subtypes based on protein expression, such as in axons. Extensions of light microscopy, such as expansion microscopy (ExM), achieve nanoscale resolution of axon terminal components without electron beams. ExM physically expands fixed tissue via hydrogel embedding, enabling ~20 nm lateral resolution of active zones in presynaptic terminals using conventional microscopes. At the neuromuscular junction, ExM has resolved active zone scaffolds and associated proteins in boutons at ~70 nm effective resolution post-expansion. Modern correlative light and electron microscopy (CLEM) integrates these modalities for multimodal imaging of terminals. CLEM aligns fluorescence-labeled terminals viewed by light microscopy with their , allowing precise correlation of molecular markers with fine anatomy, such as vesicle docking sites. This hybrid method has traced PHA-L-stained terminals from light to levels, revealing synaptic densities in brain slices.

Development and Pathology

Embryonic Formation

During embryogenesis, the initial outgrowth of axons toward their target regions is guided by extracellular cues such as netrins and semaphorins, which direct and branching decisions. Netrin-1, acting through its receptor /UNC-40, promotes axon attraction and outgrowth by activating downstream signaling pathways that reorganize the , as demonstrated in studies of commissural axons in the developing . Conversely, semaphorins, including semaphorin 3A, often exert repulsive effects to refine trajectories and prevent aberrant branching, with signaling through plexin receptors inhibiting collateral formation via Rho GTPases. These guidance molecules ensure that growing axons navigate complex environments to reach appropriate targets during early assembly. As axons contact their synaptic partners, terminal arborization occurs, elaborating branched structures that increase contact surface area; this process is promoted by target-derived cues like (BDNF). BDNF, secreted from target cells such as targets in the , binds TrkB receptors on terminals to enhance branching complexity through microtubule dynamics and , coinciding with the period of arbor patterning in and mammalian models. In mammals, initial projections begin around embryonic day 10-12 (E10-E12) in mice, with thalamocortical and corticostriatal axons extending toward their destinations shortly after neuronal birth. By E16, basic presynaptic differentiation emerges, including early vesicle clustering. Maturation of axon terminals follows synapse contact, involving the assembly of active zones and clustering of synaptic vesicles, orchestrated by adhesion molecules such as neurexins and neuroligins. Presynaptic neurexins interact trans-synaptically with postsynaptic neuroligins to recruit active zone proteins like and , stabilizing release sites and promoting vesicle docking; disruptions in these interactions impair terminal maturation and synapse function in cultured neurons and models. This refinement continues perinatally, with widespread synapse elimination shaping ; activity-dependent mechanisms, driven by competitive neural activity, reduce the initial overabundance of terminals by approximately 50%, as observed in retinogeniculate and cortical circuits where weaker are retracted to strengthen functional wiring. By birth, these processes yield more precise terminal arbors essential for mature neural communication.

Associated Disorders and Dysfunctions

In , axon terminals exhibit dystrophic changes characterized by swellings and abnormal accumulations of amyloid-beta (Aβ) peptides, which precede neuronal loss and contribute to synaptic dysfunction. These dystrophies often surround Aβ plaques, impairing and leading to disruption in presynaptic terminals. In , there is progressive loss of axon terminals in the , with estimates indicating 50-80% depletion by symptom onset, driving motor impairments through reduced release. This terminal degeneration occurs early, often before substantial neuronal cell body loss in the . Synaptic vesicle defects, such as those caused by mutations in the Munc18-1 gene (), impair at axon terminals and are linked to early infantile epileptic encephalopathies. These mutations reduce Munc18-1 levels, disrupting syntaxin-1 interactions essential for vesicle priming and neurotransmitter release, resulting in severe seizures and developmental delays. In autism spectrum disorder, disruptions in neuroligin proteins, particularly neuroligin-3 and -4 mutations, alter postsynaptic organization at , indirectly affecting presynaptic axon terminal function and leading to imbalances in excitatory-inhibitory signaling. These changes manifest as impaired striatal synapse function and repetitive behaviors in model systems. Therapeutically, (Botox) targets neuromuscular axon terminals to treat by cleaving SNAP-25, thereby inhibiting and inducing reversible muscle . This approach effectively reduces involuntary contractions in focal dystonias, with effects lasting 3-6 months post-injection. In , () imaging using synaptic vesicle protein 2A (SV2A) markers reveals reduced axon terminal density, correlating with glutamate dysregulation and supporting hypotheses of presynaptic hypofunction in prefrontal circuits. Post-2020 studies have identified inflammation-induced degeneration and swelling of axon terminals in photoreceptors of patients, where structural alterations occur without overt , potentially contributing to sensory dysfunctions. These changes are driven by SARS-CoV-2-associated immune responses, exacerbating nerve vulnerabilities in syndromes.

References

  1. [1]
    Axon Terminal - an overview | ScienceDirect Topics
    Axon terminals, also known as terminal buttons or boutons, are projections from the axon that send excitatory or inhibitory messages to the next neuron.
  2. [2]
    Neuroanatomy, Neurons - StatPearls - NCBI Bookshelf
    When an action potential reaches the axon terminal of the motor neuron, voltage-dependent calcium channels open and accommodate the influx of calcium. This ...
  3. [3]
    Histology, Axon - StatPearls - NCBI Bookshelf - NIH
    Axons are the elongated portion of the neuron located in the center of the cell between the soma and axon terminals.Introduction · Structure · Function · Microscopy, Light
  4. [4]
    Organization of Cell Types (Section 1, Chapter 8) Neuroscience ...
    The cone-shaped region of the cell body where the axon originates is termed the axon hillock. This area is free of ribosomes and most other cell organelles, ...
  5. [5]
    Axons | SynapseWeb - University of Texas at Austin
    Swellings termed axonal varicosities / boutons are typically the sites where synapses occur. Boutons form as terminal bulbs at the end of an axon, and/or ...Missing: PNS | Show results with:PNS
  6. [6]
  7. [7]
    Physiology, Neuromuscular Transmission - StatPearls - NCBI - NIH
    Mar 9, 2025 · The neuromuscular junction (NMJ) is responsible for the chemical transmission of electrical impulses from nerves to muscles (skeletal, smooth, or cardiac)
  8. [8]
  9. [9]
  10. [10]
  11. [11]
  12. [12]
  13. [13]
  14. [14]
    Physiology, Synapse - StatPearls - NCBI Bookshelf
    Mar 27, 2023 · Axons are generally the outflow tracts of the neuron. It is a cylindrical tube covered by the axolemma and supported by neurofilaments and ...
  15. [15]
    Chapter 4: Synaptic Transmission and the Skeletal Neuromuscular ...
    The synapse is a specialized structure that allows one neuron to communicate with another neuron or a muscle cell.
  16. [16]
    Inhibitory and excitatory axon terminals share a common nano ...
    Tuning of the time course and strength of inhibitory and excitatory neurotransmitter release is fundamental for the precise operation of cortical network ...
  17. [17]
    Structure and evolution of neuronal wiring receptors and ligands
    In this review, we look at the families of cell surface and secreted molecules with demonstrated functions in axon guidance, synapse targeting, and formation.
  18. [18]
    Physiology, Action Potential - StatPearls - NCBI Bookshelf - NIH
    An action potential is a rapid voltage change across a membrane, involving depolarization (sodium) and repolarization (potassium) in neurons.
  19. [19]
    Action potentials reliably invade axonal arbors of rat neocortical ...
    Action potentials can invade these arbors and cause calcium influx that is required for neurotransmitter release and excitation of postsynaptic targets. Thus, ...
  20. [20]
    Action Potential Reflection and Failure at Axon Branch Points Cause ...
    At the same branch points action potentials may fail to propagate, which can reduce transmission. It is now shown that presynaptic action potential reflection ...<|control11|><|separator|>
  21. [21]
    The Nodes of Ranvier: Molecular Assembly and Maintenance - PMC
    Action potentials (APs) generated at the axon initial segment (AIS) travel down the axon and are regenerated at the nodes of Ranvier until reaching the nerve ...
  22. [22]
    SNAP receptors implicated in vesicle targeting and fusion - Nature
    Mar 25, 1993 · The existence of numerous SNARE-related proteins, each apparently specific for a single kind of vesicle or target membrane, indicates that NSF ...
  23. [23]
    SNARE Complex Formation & Membrane Fusion Driven by Ca2+
    Neurotransmitter exocytosis, a process mediated by a core complex of syntaxin, SNAP-25, and VAMP (SNAREs), is inhibited by SNARE-cleaving neurotoxins.Missing: paper | Show results with:paper
  24. [24]
    The Synaptic Vesicle Cycle Revisited: New Insights into the Modes ...
    Oct 16, 2019 · They proposed that SVs can be recycled by the reversal of an exocytic fusion pore, a model that was later termed “kiss-and-run” (Fig. 1) (Fesce ...
  25. [25]
    Article Presynaptic Depolarization Rate Controls Transmission at an ...
    Measurement of postsynaptic currents showed that neurotransmitter release occurs within a 2 ms period. Consequently, IPSP amplitude is not influenced by the ...Missing: post- | Show results with:post-
  26. [26]
    Article Systematic Heterogeneity of Fractional Vesicle Pool Sizes ...
    The readily releasable pool (RRP) of 5–10 vesicles is already docked to the active zone and primed for fusion. The RRP can be released immediately upon a rapid ...
  27. [27]
    Functions of Presynaptic Voltage-gated Calcium Channels - PMC
    The molecular and biophysical properties of CaV channels are finely tuned to their roles in presynaptic terminals to mediate neurotransmitter release. Although ...
  28. [28]
    Calcium Control of Neurotransmitter Release - PMC - PubMed Central
    Calcium influx triggers neurotransmitter release by activating synaptotagmins, which bind calcium and trigger membrane fusion, with a speed of a few hundred ...
  29. [29]
  30. [30]
    Synaptotagmin: a Calcium Sensor on the Synaptic Vesicle Surface
    Abstract. Neurons release neurotransmitters by calcium-dependent exocytosis of synaptic vesicles. However, the molecular steps transducing the calcium signal ...
  31. [31]
    Quantitative Relationship between Transmitter Release and ...
    Second, the cooperativity of transmitter release as a function of Ca2+ current was estimated to be 3–4, which confirmed previous results (Borst and Sakmann, ...
  32. [32]
    Presynaptic Calcium Influx Controls Neurotransmitter Release
    Mar 13, 2013 · Fits to the Hill equation revealed that the EPSC amplitude is very steeply dependent on Cainflux (Hill coefficient (n) = 5.6, Ca1/2 = 0.96) ...
  33. [33]
    Presynaptic calcium channels
    ### Summary on Modulation of Presynaptic Ca²⁺ Channels by Autoreceptors and Second Messengers like cAMP
  34. [34]
    Rapid Ca2+ channel accumulation contributes to cAMP-mediated ...
    Feb 23, 2021 · This study suggests a potential mechanism for the cAMP-dependent increase in transmission at hippocampal mossy fiber-CA3 synapses, namely an accumulation of ...
  35. [35]
    Presynaptic cAMP-PKA-mediated potentiation induces ...
    Presynaptic cAMP-PKA-mediated potentiation induces reconfiguration of synaptic vesicle pools and channel-vesicle coupling at hippocampal mossy fiber boutons.
  36. [36]
    A Review of Calcium Activity Analysis Methods Employed to Identify ...
    These types of calcium signaling events can be visualized by using calcium imaging techniques such as using calcium-sensitive marker dyes (e.g., Fluo-4 or Fura ...
  37. [37]
    Fast and sensitive GCaMP calcium indicators for neuronal imaging
    Feb 22, 2023 · We review the principles of development and deployment of genetically encoded calcium indicators (GECIs) for the detection of neural activity.
  38. [38]
    Studying vesicle cycling in presynaptic terminals using the ... - PubMed
    Studies of synaptic vesicle recycling have been facilitated by a group of GFP-derived probes called pHluorins. These probes exploit changes in pH that accompany ...
  39. [39]
    The Use of pHluorins for Optical Measurements of Presynaptic Activity
    Here we have characterized the use of pHluorins for measuring exocytosis at synaptic terminals, determined their pK, and provide an analytical framework for ...
  40. [40]
    Glutamate indicators with improved activation kinetics and ... - Nature
    May 4, 2023 · The fluorescent glutamate indicator iGluSnFR enables imaging of neurotransmission with genetic and molecular specificity.
  41. [41]
    Release probability of hippocampal glutamatergic terminals scales ...
    To measure the release probability and short-term plasticity of CA3 pyramidal cell local axon collaterals, we performed two-photon imaging of [Ca2+] transients ...
  42. [42]
    STED Imaging of Vesicular Endocytosis in the Synapse - PMC
    Super-resolution microscopy enables optical imaging of exocytosis and endocytosis in live cells and makes an essential contribution to understanding molecular ...
  43. [43]
    All-optical presynaptic plasticity induction by photoactivated adenylyl ...
    Mar 22, 2024 · Optogenetic stimulation of PB terminals in the CeA with ChR2 generates several unconditioned aversive responses, including immobile behavior.
  44. [44]
    [PDF] Projection-Specific Intersectional Optogenetics for Precise Excitation ...
    Aug 15, 2025 · The direct excitatory and inhibitory optogenetic methods explored in this study achieve high labeling specificity through a viral intersection ...
  45. [45]
    [PDF] Santiago Ramón y Cajal - Nobel Lecture
    We applied Golgi's method, firstly in the cerebellum and then in the spinal cord, the cerebrum, the ol- factory bulb, the optic lobe, the retina and so on of ...Missing: 1890s | Show results with:1890s
  46. [46]
    Santiago Felipe Ramon y Cajal (1852-1934)
    Jun 5, 2014 · The Golgi staining technique enabled clear observations of cells, which proved that neurons are individual cells. Scientists called the theory ...
  47. [47]
    Exploiting volume electron microscopy to investigate structural ...
    Mar 23, 2023 · The ability of the Electron Microscope (EM) to achieve nanometric resolution makes it the best instrument to visualize synapse ultrastructure.
  48. [48]
    Serial Section Scanning Electron Microscopy of Adult Brain Tissue ...
    Mar 19, 2008 · With a resolution capable of seeing the smallest synaptic contacts, this method uses different sectioning techniques to produce serial images ...
  49. [49]
    A Novel Procedure for Pre-embedding Double Immunogold–Silver ...
    Large particles labeling synaptophysin are found amid synaptic vesicles in axon terminals (asterisks). Bars: A = 210 nm; B = 240 nm. It should be pointed ...
  50. [50]
    Immunogold labeling of synaptic vesicle proteins in developing ...
    The present study used pre-embedding immunogold EM to examine the distribution of various endogenous SV integral membrane proteins including synaptophysin [8], ...Missing: immuno- | Show results with:immuno-
  51. [51]
    Enhanced synaptic protein visualization by multicolor super ...
    We developed a method that enables 4-color fluorescence imaging of synaptic proteins in neurons with 20 to 30 nm lateral resolution.
  52. [52]
    Superresolution imaging of Drosophila tissues using expansion ...
    Jun 14, 2018 · First, we show that ExM allows for high-resolution analysis of presynaptic active zone (AZ) structure at the larval neuromuscular junction (NMJ) ...
  53. [53]
    A Correlative Light and Electron Microscopic Study of Axon ...
    Thus, axon terminals stained with PHA-L can be identified reliably at the light microscopic level, but synaptic density will be slightly underestimated. One- ...
  54. [54]
    Building thalamic neuronal networks during mouse development
    Feb 3, 2023 · In the developing mouse thalamus, prospective thalamocortical cells begin to extend their axons toward the cortex at around E12, shortly after ...
  55. [55]
  56. [56]
    Axonal Degeneration in AD: The Contribution of Aβ and Tau - PMC
    In this context, progressive axonal degeneration has been associated with early stages of AD and linked to Aβ and tau accumulation. As the axonal degeneration ...
  57. [57]
    Presynaptic dystrophic neurites surrounding amyloid plaques are ...
    Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal ...Murine Tissue... · Results · Aβ42 Causes Neuritic...
  58. [58]
    Striatal Dopamine Loss in Early Parkinson's Disease - NIH
    Neuropathological studies, based on small samples, suggest that symptoms of Parkinson's disease (PD) emerge when dopamine/nigrostriatal loss is around 50–80%.
  59. [59]
    Axon Degeneration in Parkinson's Disease - PMC - PubMed Central
    Estimates of dopamine terminal loss at time of disease onset are less for those obtained with [18F] dopa (20–50% in putamen) than for those obtained with ...
  60. [60]
    Functional analysis of epilepsy‐associated variants in STXBP1 ... - NIH
    Genetic variants in STXBP1, which encodes the conserved exocytosis protein Munc18‐1, are associated with a variety of infantile epilepsy syndromes.
  61. [61]
    Reduced MUNC18-1 Levels, Synaptic Proteome Changes, and ...
    Its gene product MUNC18-1 organizes synaptic vesicle exocytosis and is essential for synaptic transmission. Patients present with developmental delay ...Archival Report · Munc18-1 Protein And Rna... · Stxbp1-Rd Neurons Maintain...
  62. [62]
    Synaptopathology Involved in Autism Spectrum Disorder - PMC
    Disorder-associated mutations lead to functional inactivation of neuroligins ... Autism-related neuroligin-3 mutation alters social behavior and spatial learning.
  63. [63]
    Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal ...
    Jul 3, 2014 · Different autism-associated neuroligin-3 mutations cause a common increase in acquired repetitive behaviors by impairing a specific striatal synapse.Missing: axon | Show results with:axon
  64. [64]
    BOTULINUM TOXIN - PMC - NIH
    Intramuscular administration of botulinum toxin acts at the neuromuscular junction to cause muscle paralysis by inhibiting the release of acetylcholine from ...
  65. [65]
    Use of botulinum toxin for movement disorders - PubMed Central
    BoNT is the standard treatment for focal and segmental dystonias. The recommended levels for the treatment of dystonia and other movement disorders with BoNTs ...
  66. [66]
    The relationship between synaptic density marker SV2A, glutamate ...
    Glutamatergic excitotoxicity is hypothesised to underlie synaptic loss in schizophrenia pathogenesis, but it is unknown whether synaptic markers are related ...
  67. [67]
    Microglia activation and neuronal alterations in retinas from COVID ...
    Mar 1, 2023 · COVID-19 retinas showed swelling at the axon terminal of cone photoreceptors but cell death was not detectable. Cone photoreceptors of retinas ...
  68. [68]
    Peripheral nervous system involvement associated with COVID-19 ...
    Apr 6, 2023 · PNS involvement in COVID-19 may be an important cause of hospitalization and post COVID-19 sequelae, increasing the burden on the healthcare systems.